Evidence map›Paper›PMID 41053528›Full record

ReviewJournal of nephrology2025

Kidney failure in the course of focal segmental glomerulonephritis in a patient after alloHSCT - a case study and review of the literature.

Aleksandra Kaszyńska, Małgorzata Kępska-Dzilińska, Ewa Karakulska-Prystupiuk, Agnieszka Perkowska-Ptasińska, Jolanta Małyszko

Abstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Aleksandra KaszyńskaDepartment of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Banacha 1A, 02-097, Warsaw, Poland.
Małgorzata Kępska-DzilińskaDepartment of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Banacha 1A, 02-097, Warsaw, Poland.
Ewa Karakulska-PrystupiukDepartment of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Banacha 1A, 02-097, Warsaw, Poland.
Agnieszka Perkowska-PtasińskaDepartment of Pathology, Medical University of Warsaw, Pawinskiego 3, 02-097, Warsaw, Poland.
Jolanta MałyszkoDepartment of Nephrology, Dialysis and Internal Medicine, Medical University of Warsaw, Banacha 1A, 02-097, Warsaw, Poland. jolmal@poczta.onet.pl.ORCID http://orcid.org/0000-0001-8701-8171

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephrotic syndrome is a rare complication of allogeneic haematopoietic stem cell transplantation (alloHSCT). Its pathogenesis is not fully understood. Membranous nephropathy and minimal change disease are the most common causes of nephrotic syndrome. Nephrotic syndrome occurs more frequently in people with chronic graft-versus-host disease (GvHD). Glucocorticosteroids and cyclosporine are the most common treatments, but their use is associated with the risk of side effects and variable responses. We present a case of a patient after alloHSCT with advanced GvHD who developed nephrotic syndrome resistant to immunosuppressive treatment. Additionally, when her kidney function deteriorated, she required kidney replacement therapy. We would like to emphasise the importance of kidney biopsy as a tool for determining the extent of kidney damage and the possible response to therapy.

Indexed as

Glomerulosclerosis, Focal SegmentalGraft vs Host DiseaseHematopoietic Stem Cell TransplantationNephrotic SyndromeRenal InsufficiencyAdultBiopsyFemaleHumansImmunosuppressive AgentsKidneyTransplantation, HomologousTreatment OutcomeImmunosuppressive AgentsAllogenic stem cell transplantationFocal segmental glomerulosclerosisGraft versus host diseaseNephrotic syndromeRuxolitinib

Identifiers

PMID41053528
PMCPMC12712002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.